vs
FLAGSTAR BANK, NATIONAL ASSOCIATION（FLG）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是FLAGSTAR BANK, NATIONAL ASSOCIATION的1.2倍（$622.0M vs $498.0M），Royalty Pharma plc净利率更高（34.4% vs 4.2%，领先30.2%），Royalty Pharma plc同比增速更快（4.8% vs 1.6%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -10.7%）
Flagstar银行是原总部位于美国密歇根州特洛伊的商业银行，成立于1987年，主营零售及商业银行业务、抵押贷款发放及各类金融服务。其控股公司于2022年12月被纽约社区银行收购，后者后将全部门店统一为Flagstar品牌，2024年更名为Flagstar Financial，2025年启动企业重组。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FLG vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$498.0M
营收增速更快
RPRX
高出3.1%
1.6%
净利率更高
RPRX
高出30.2%
4.2%
两年增速更快
RPRX
近两年复合增速
-10.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $498.0M | $622.0M |
| 净利润 | $21.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 11.4% | 62.4% |
| 净利率 | 4.2% | 34.4% |
| 营收同比 | 1.6% | 4.8% |
| 净利润同比 | -38.1% | 2.9% |
| 每股收益（稀释后） | $0.03 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLGRPRX
| Q1 26 | $498.0M | — | ||
| Q4 25 | $2.1B | $622.0M | ||
| Q3 25 | $425.0M | $609.3M | ||
| Q2 25 | $419.0M | $578.7M | ||
| Q1 25 | — | $568.2M | ||
| Q4 24 | $461.0M | $593.6M | ||
| Q3 24 | $510.0M | $564.7M | ||
| Q2 24 | $557.0M | $537.3M |
净利润FLGRPRX
| Q1 26 | $21.0M | — | ||
| Q4 25 | $29.0M | $214.2M | ||
| Q3 25 | $-36.0M | $288.2M | ||
| Q2 25 | $-70.0M | $30.2M | ||
| Q1 25 | — | $238.3M | ||
| Q4 24 | $-188.0M | $208.2M | ||
| Q3 24 | $-280.0M | $544.0M | ||
| Q2 24 | $-323.0M | $102.0M |
营业利润率FLGRPRX
| Q1 26 | 11.4% | — | ||
| Q4 25 | — | 62.4% | ||
| Q3 25 | -9.6% | 70.1% | ||
| Q2 25 | -19.3% | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | -51.6% | 60.9% | ||
| Q3 24 | -65.7% | — | ||
| Q2 24 | -76.1% | 50.2% |
净利率FLGRPRX
| Q1 26 | 4.2% | — | ||
| Q4 25 | 1.4% | 34.4% | ||
| Q3 25 | -8.5% | 47.3% | ||
| Q2 25 | -16.7% | 5.2% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | -40.8% | 35.1% | ||
| Q3 24 | -54.9% | 96.3% | ||
| Q2 24 | -58.0% | 19.0% |
每股收益（稀释后）FLGRPRX
| Q1 26 | $0.03 | — | ||
| Q4 25 | $0.05 | $0.49 | ||
| Q3 25 | $-0.11 | $0.67 | ||
| Q2 25 | $-0.19 | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | $-1.11 | $0.46 | ||
| Q3 24 | $-0.79 | $1.21 | ||
| Q2 24 | $-1.14 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $8.1B | $9.7B |
| 总资产 | $87.1B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FLGRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $618.7M | ||
| Q3 25 | $23.6B | $938.9M | ||
| Q2 25 | $22.9B | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $25.8B | $929.0M | ||
| Q3 24 | $33.6B | $950.1M | ||
| Q2 24 | $29.5B | $1.8B |
总债务FLGRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | $13.2B | $8.9B | ||
| Q2 25 | $13.2B | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $14.4B | $7.6B | ||
| Q3 24 | $20.3B | $7.6B | ||
| Q2 24 | $28.9B | $7.6B |
股东权益FLGRPRX
| Q1 26 | $8.1B | — | ||
| Q4 25 | $8.1M | $9.7B | ||
| Q3 25 | $8.1B | $9.6B | ||
| Q2 25 | $8.1B | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | $8.2B | $10.3B | ||
| Q3 24 | $8.6B | $10.3B | ||
| Q2 24 | $8.4B | $9.8B |
总资产FLGRPRX
| Q1 26 | $87.1B | — | ||
| Q4 25 | $87.5M | $19.6B | ||
| Q3 25 | $91.7B | $19.3B | ||
| Q2 25 | $92.2B | $18.3B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | $100.2B | $18.2B | ||
| Q3 24 | $114.4B | $18.0B | ||
| Q2 24 | $119.1B | $17.7B |
负债/权益比FLGRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | 1.63× | 0.93× | ||
| Q2 25 | 1.63× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 1.77× | 0.74× | ||
| Q3 24 | 2.37× | 0.74× | ||
| Q2 24 | 3.44× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FLGRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $827.1M | ||
| Q3 25 | $243.0M | $702.6M | ||
| Q2 25 | — | $364.0M | ||
| Q1 25 | — | $596.1M | ||
| Q4 24 | $623.0M | $742.5M | ||
| Q3 24 | $-1.0B | $703.6M | ||
| Q2 24 | $796.0M | $658.2M |
现金转化率FLGRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLG
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
